Results 71 to 80 of about 63,096 (190)

Subversion of host innate immunity by uropathogenic Escherichia coli [PDF]

open access: yes, 2016
Uropathogenic Escherichia coli (UPEC) cause the majority of community-onset urinary tract infections (UTI) and represent a major etiologic agent of healthcare-associated UTI.
Cavalieri   +5 more
core   +3 more sources

THE INFLUENCE OF PYELONEPHRITIS COMPLICATIONS ON COURSE OF PREGNANCY AND LABOR [PDF]

open access: yes, 2014
Pyelonephritis - nonspecific, infectious-inflammatory process with primary and primary lesion interstitial tissue walls and renal tubules, with subsequent involvement of glomerular and vascular system.
Ashish, D., Bakun, O.V.
core  

Xanthogranulomatous Pyelonephritis.

open access: yesInternal Medicine, 1997
A 76-year-old woman presented with spiking fever and right back pain. Ultrasonography (US) revealed that her right kidney was enlarged. Computed tomography (CT) showed the parenchyma was replaced by non-enhancing masses but the overall kidney shape was maintained. These findings were compatible with those of xanthogranulomatous pyelonephritis (XP). The
T, Muta   +4 more
openaire   +3 more sources

Comparison of type and antibiotic resistance of microorganisms causing pyelonephritis in children with and without functional constipation [PDF]

open access: yesمجله پزشکی دانشگاه علوم پزشکی تبریز
Background. As mentioned, in this study we compared the type of microorganisms causing pyelonephritis and their resistance in two groups of children with and without constipation. This issue is very important in the clinic in initial empirical treatment (
Mohsen Mohammadi   +5 more
doaj   +1 more source

Periportal Edema as an Extrarenal Manifestation of Acute Pyelonephritis

open access: yesDiagnostics
Acute pyelonephritis is a common infection of the upper urinary tract that affects approximately 250,000 adults in the United States. Individuals with acute pyelonephritis require hospitalization and intravenous antimicrobial therapy.
Yu-Yun Chang, Kuei-Hong Kuo
doaj   +1 more source

Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis

open access: yesDisease Models & Mechanisms, 2017
We present a new preclinical model to study treatment, resolution and sequelae of severe ascending pyelonephritis. Urinary tract infection (UTI), primarily caused by uropathogenic Escherichia coli (UPEC), is a common disease in children.
Patrick D. Olson   +7 more
doaj   +1 more source

Phenotypic microarrays suggest Escherichia coli ST131 is not a metabolically distinct lineage of extra-intestinal pathogenic E. coli [PDF]

open access: yes, 2014
Extraintestinal pathogenic E. coli (ExPEC) are the major aetiological agent of urinary tract infections (UTIs) in humans. The emergence of the CTX-M producing clone E. coli ST131 represents a major challenge to public health worldwide.
A Coelho   +46 more
core   +2 more sources

Pyelonephritis [PDF]

open access: yes, 1978
The purpose of this paper is to review current thinking about pyelonephritis. Pyelonephritis may be defined as a bacterial infection of the kidney which affects the parenchyma, the pelvis, and the calyces.
Falls, William F., Jr.
core   +1 more source

A brief review of the literature on the malignant ureteral obstruction [PDF]

open access: yes, 2018
Malignant ureteral obstruction (MUO) caused by a primarily urological tumor or secondary to a late-stage malignancy can be difficult for the urologist to manage. Due to a lack of clinical data on the management of MUO, every case is particular and should
Brînză, Adrian   +7 more
core   +1 more source

Complicated case of bilateral emphysematous pyelonephritis and emphysematous cystitis successfully treated with transurethral drainage and ureteral stents

open access: yesUrology Case Reports
Emphysematous pyelonephritis and emphysematous cystitis are intractable diseases. Eight cases of bilateral emphysematous pyelonephritis and emphysematous cystitis have been reported, but no treatment has been established.
Yoshihiro Kawaguchi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy